Address: ul. Jutrzenki 94
02-230 Warszawa
Tel: +48 22 824 97 32
Web: http://www.blaufarma.pl/?pId=produkty_glowna
Founded in 2001, BLAU FARMA is Polish private specialty pharmaceutical company focused on dermatology.
The company is centered on development, manufacturing and marketing of innovative, safe and effective prescription and over-the-counter preparations that importantly improve the lives of patients suffering from conditions related to skin diseases (such as acne, steroid-sensitive dermatoses, fungal and bacterial infections), as well as dermocosmetics lines of products that aid each individual to optimize their skin’s health.
The second BLAU FARMA’s business area is parallel import of medicinal products. Today, the company is parallel importer No 3 in Poland. We strongly believe that stimulating competition in the pharmaceutical market enables broader access to better treatment options for greater number of patients.
Quality is a cornerstone of all BLAU FARMA’s of activities. The company seeks the highest quality information, decisions and people, and produces high quality products.
BLAU FARMA’s goal is to become the number one in Poland among dermatology-focused pharmaceutical companies and to enter European export markets.
With the headquarter in Warsaw, BLAU FARMA employs 56 highly skilled and efficient full-time employees.
The company holds integrity, responsibility and professionalism above all else. Also cherishes hard work, productivity, loyalty, accountability, leadership, teamwork, creativity, initiative, courage, enthusiasm and optimism.
Prescription and non prescription pharmaceutical in dermatology.
Parallel imports of dermatology products as well as expanding ophthamological products.
Stefan Buguslawski, president of PEX Pharmasequence, a leading Polish healthcare consultancy and market research company, highlights the current obstacles facing the Polish healthcare market and the dynamics of the domestic…
Piotr Ponikowski, president of the Polish Cardiac Society, discusses the positive steps Poland is taking to construct an effective program against cardiovascular disease as well as the importance of a…
Wojciech Sulimierski, general manager of Aspen Poland and CEE, discusses the opening of the regional operations in 2014 and the importance of the CEE region as the company establishes itself…
Jarek Oleszczuk, country president of AstraZeneca Poland, the leading R&D investor in Poland, discusses the exciting milestones that the company has achieved, including reimbursement of two breakthrough oncology therapies, as…
Drago Vuina, corporate vice-president of Novo Nordisk Eastern Europe, highlights Poland as the most significant market in the region and the on-going commitment to make innovative treatment options available for…
Jakub Szulc, director of life sciences at EY Poland, discusses the exciting opportunities that exist within the healthcare sector in the flourishing Polish economy and the overriding need to increase…
Samantha Kingdom, general manager of Amgen Poland, highlights her strategy to be a significant contributor within the Polish healthcare space, while delivering highly innovative products to significantly improve Polish patients’…
Jacek Mazurkiewicz, general manager of AbbVie Poland, discusses the recent exciting achievements of the affiliate, including the reimbursement of its products in recent years and the set up one of…
Maciej Kuźmierkiewicz, general manager of IQVIA Poland and the Baltics, discusses the implications of global changes on the Polish affiliate (which now employs 1000 staff) and the challenges of promoting…
Wojciech Koziejowski, managing director of Lundbeck Poland, discusses attaining reimbursement in Poland for the first time in ten years and the recent set-up of their global shared service center of…
Denis Vujičić, managing director of MSD Poland, discusses his overriding mission to give Polish patients greater access to breakthrough therapies and highlights the affiliate’s extensive R&D capabilities that entail both…
Irena Rej, president of the Polish Pharmaceutical Chamber, Farmacja Polska, discusses the trends of the domestic pharmaceutical market and the recent changes to improve the introduction of innovative products. Furthermore,…
See our Cookie Privacy Policy Here
